Institute of Health & Society

Staff Profile

Melissa Girling

NIHR Research Fellow

Background

My research interests are mental health and addictions. I have been involved in research and evaluation that is concerned with providing timely and on-going responses to mental health and addiction issues through monitoring and outcome measures; assessing the psychological and social impact of these issues on individuals and groups; investigating the efficiency and effectiveness of programmes and interventions to address such issues and providing appropriate recommendations for positive outcomes. I also have a strong interest and experience in developing research tools and outcome measures (both qualitative and quantitative); working with vulnerable population groups and methodological approaches for conducting culturally informed research. I have worked both in the UK and New Zealand.

Areas of expertise

·         Qualitative and co-design research methods

·         Young people and young justice

·         Mental health

Teaching

 

 

Publications

  • Finch T, Girling M, May C, Mair F, Murray E, Treweek S, Steen I, McColl E, Dickinson C, Rapley T. Can we measure implementation progress using normalization process theory? Development and validation of the NoMAD survey tool. In: 48th Congress of the International Society of Paediatric Oncology (SIOP). 2016, Dublin, Ireland: Springer.
  • Bowyer H, Exley C, Girling M, Tweddle D. Delays to Diagnosis of Childhood Cancer: A Qualitative Study of Specialist Health Care Professionals' Views. In: 48th Congress of the International Society of Paediatric Oncology (SIOP). 2016, Dublin: John Wiley & Sons, Inc.
  • Finch TL, Rapley T, Girling M, Mair FS, Murray E, Treweek S, McColl E, Steen IN, May CR. Improving the Normalization of Complex Interventions: Measure Development based on Normalization Process Theory (NoMAD): Study Protocol. Implementation Science 2013, 8(43), 1-8.
  • Wilkins C, Sweetsur P, Girling M. Patterns of benzylpiperazine/ trifluoromethylphenylpiperazine (BZP/TFMPP) party pill use and adverse effects in a population sample in New Zealand. Drug and Alcohol Review 2008, 27(6), 633-639.
  • Witten K, Girling M, Neale J. BRCSS Portfolio Research Programmes Survey. Auckland, New Zealand: Centre for Social and Health Outcomes Research and Evaluation (SHORE) & Te Ropu Whariki, Massey University, 2007.
  • Wilkins C, Girling M, Sweetsur P. The prevalence of use, dependency and harms of legal 'party pills' containing benzylpiperazine (BZP) and trifluorophenylmethylpiperazine (TFMPP) in New Zealand. Journal of Substance Abuse 2007, 3, 213-224.
  • Girling M, Huakau J, Casswell S, Conway K. Families and Heavy Drinking: Impacts on Parenting and Children’s Well-being. A Systematic Review. Auckland, New Zealand: Centre for Social and Health Outcomes Research and Evaluation (SHORE) & Te Ropu Whariki, Massey University. (Families Commission), 2006.
  • Wilkins C, Girling M, Sweetsur P. Findings from the combined modules of the 2006 Illicit Drug Monitoring System (IDMS). Auckland, New Zealand: Centre for Social and Health Outcomes Research and Evaluation (SHORE) and Te Ropu Whariki, Massey University, 2006.
  • Wilkins C, Girling M, Sweetsur P. Legal party pill use in New Zealand: Prevalence of use, availability, health harms and ‘gateway effects’ of benzylpiperazine (BZP) and triflourophenylmethylpiperazine (TFMPP). Auckland, New Zealand: Centre for Social and Health Outcomes Research and Evaluation (SHORE) & Te Ropu Whariki, Massey University, 2006.
  • Wilkins C, Girling M, Sweetsur P, Butler R. Methamphetamine and Other Illicit Drug Trends in New Zealand, 2005: Findings from the Methamphetamine Module of the 2005 Illicit Drug Monitoring System (IDMS). Auckland, New Zealand: Centre for Social and Health Outcomes Research and Evaluation (SHORE) & Te Ropu Whariki, Massey University, 2005.